Whitcup Scott M
Insider CIK 1298941 · ADVM Director · MNLO Director · NITE Director · AGN Executive VP, R&D, CSO · AVNR Director · QCOR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 6,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-05-12 | 2021-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-06-23 | 2020-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-04-16 | 2020-04-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-08-08 | 22,500 | — | $0 | 134,099 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 22,500 | — | $0 | 134,099 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer deriv | 2019-06-07 | 2019-06-07 | 18,200 | $13.23 | $240.8K | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer deriv | 2019-06-07 | 2019-06-07 | 21,000 | $11.93 | $250.5K | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer | 2019-06-07 | 2019-06-07 | 74,568 | $25.50 | $1.90M | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | A Award deriv | 2019-01-25 | 2019-01-29 | 21,000 | — | $0 | 21,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise deriv | 2019-01-14 | 2019-01-15 | 25,000 | $1.83 | $45.8K | 77,043 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 120,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 67,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 25,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 60,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 58,815 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 92,600 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 130,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 105,500 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 89,200 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2015-03-17 | 2015-03-19 | 11,274 | — | $0 | 18,683 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 18,683 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 1,739 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 1,710 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2015-02-20 | 2015-02-24 | 212 | — | $0 | 212 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2015-02-20 | 2015-02-24 | 212 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2015-02-20 | 2015-02-24 | 80 | $234.00 | $18.7K | 17,175 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2015-02-20 | 2015-02-24 | 212 | — | $0 | 17,255 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2015-02-20 | 2015-03-19 | 9,766 | — | $0 | 7,409 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 3,803 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 9,203 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 13,530 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-08-14 | 2014-08-18 | 4,183 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2014-02-21 | 2014-02-25 | 58,815 | $125.07 | $7.36M | 58,815 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2014-02-14 | 2014-02-19 | 284 | $124.57 | $35.4K | 17,043 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2014-01-14 | 2014-01-15 | 42,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-01-14 | 2014-01-15 | 21,000 | $116.80 | $2.45M | 38,327 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-01-14 | 2014-01-15 | 21,000 | $118.80 | $2.49M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2014-01-14 | 2014-01-15 | 42,000 | $55.98 | $2.35M | 59,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-01-08 | 2014-01-10 | 21,000 | $114.80 | $2.41M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-01-08 | 2014-01-10 | 21,000 | $112.80 | $2.37M | 38,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2014-01-08 | 2014-01-10 | 42,000 | $55.98 | $2.35M | 59,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2014-01-03 | 2014-01-07 | 24,200 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-01-03 | 2014-01-07 | 24,200 | $111.80 | $2.71M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2014-01-03 | 2014-01-07 | 24,200 | $36.15 | $874.8K | 41,527 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-12-20 | 2014-01-06 | 16,500 | — | $0 | 24,200 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-12-20 | 2014-01-06 | 16,500 | — | $0 | 40,700 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-12-20 | 2014-01-06 | 16,500 | $107.80 | $1.78M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-12-20 | 2014-01-06 | 16,500 | — | $0 | 33,827 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-12-20 | 2014-01-06 | 16,500 | — | $0 | 33,827 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-12-20 | 2014-01-06 | 16,500 | $109.80 | $1.81M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-12-20 | 2013-12-20 | 16,500 | — | $0 | 24,200 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-12-20 | 2013-12-20 | 16,500 | — | $0 | 40,700 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-12-20 | 2013-12-20 | 16,500 | $36.15 | $596.5K | 33,827 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-12-20 | 2013-12-20 | 16,500 | $109.80 | $1.81M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-12-20 | 2013-12-20 | 16,500 | $36.15 | $596.5K | 33,827 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-12-20 | 2013-12-20 | 16,500 | $107.80 | $1.78M | 17,327 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2013-05-24 | 2013-05-29 | 9,203 | — | $0 | 9,203 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-05-24 | 2013-05-29 | 4,183 | — | $0 | 4,183 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-04-11 | 2013-04-15 | 12,005 | — | $0 | 57,200 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-04-11 | 2013-04-15 | 12,005 | $115.00 | $1.38M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-04-11 | 2013-04-15 | 12,005 | $36.15 | $434.0K | 29,332 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-04-03 | 2013-04-05 | 13,195 | — | $0 | 69,205 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-04-03 | 2013-04-05 | 13,195 | $36.15 | $477.0K | 30,522 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-04-03 | 2013-04-05 | 13,195 | $115.00 | $1.52M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-04-01 | 2013-04-02 | 8,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-04-01 | 2013-04-02 | 8,000 | $41.24 | $329.9K | 25,327 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-04-01 | 2013-04-02 | 8,000 | $111.70 | $893.6K | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-03-26 | 2013-03-27 | 11,484 | — | $0 | 82,400 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-03-26 | 2013-03-27 | 11,484 | $112.00 | $1.29M | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-03-26 | 2013-03-27 | 11,484 | $36.15 | $415.1K | 28,811 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-03-25 | 2013-03-25 | 4,925 | — | $0 | 93,884 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-03-25 | 2013-03-25 | 4,925 | $36.15 | $178.0K | 22,252 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-03-25 | 2013-03-25 | 4,925 | $112.00 | $551.6K | 17,327 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-03-21 | 2013-03-25 | 1,191 | — | $0 | 98,809 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-03-21 | 2013-03-25 | 1,191 | $36.15 | $43.1K | 18,518 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-03-21 | 2013-03-25 | 1,191 | $112.00 | $133.4K | 17,327 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2013-02-21 | 2013-02-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2013-02-20 | 2013-02-22 | 5,218 | $108.08 | $564.0K | 17,327 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2013-02-15 | 2013-02-20 | 434 | $108.02 | $46.9K | 22,545 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2013-02-14 | 2013-02-19 | 38,900 | — | $0 | 306,494 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-01-04 | 2013-01-07 | 24,000 | — | $0 | 8,000 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-01-04 | 2013-01-07 | 24,000 | $41.24 | $989.8K | 46,979 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-01-04 | 2013-01-07 | 24,000 | $96.80 | $2.32M | 22,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-12-07 | 2012-12-11 | 6,800 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-12-07 | 2012-12-11 | 6,800 | $30.13 | $204.9K | 29,779 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-12-07 | 2012-12-11 | 6,800 | $91.23 | $620.4K | 22,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-10-17 | 2012-10-18 | 5,000 | — | $0 | 6,800 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-10-17 | 2012-10-18 | 5,000 | $94.70 | $473.5K | 22,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-10-17 | 2012-10-18 | 5,000 | $30.13 | $150.7K | 27,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-10-01 | 2012-10-02 | 6,000 | — | $0 | 11,800 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-10-01 | 2012-10-02 | 6,000 | $92.70 | $556.2K | 22,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-10-01 | 2012-10-02 | 6,000 | $30.13 | $180.8K | 28,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-05-30 | 2012-05-31 | 1,500 | — | $0 | 17,800 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-05-30 | 2012-05-31 | 1,500 | $90.71 | $136.1K | 22,979 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-05-30 | 2012-05-31 | 1,500 | $30.13 | $45.2K | 24,479 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-05-16 | 2012-05-18 | 1,500 | — | $0 | 19,300 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-05-16 | 2012-05-18 | 1,500 | $30.13 | $45.2K | 24,479 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-05-16 | 2012-05-18 | 1,500 | $92.00 | $138.0K | 22,979 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2012-05-10 | 2012-05-14 | 3,803 | — | $0 | 3,803 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-02-22 | 2012-02-24 | 45 | $87.27 | $3.9K | 22,979 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-02-17 | 2012-02-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-02-17 | 2012-02-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-02-17 | 2012-02-22 | 544 | — | $0 | 23,024 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-02-16 | 2012-02-17 | 30,000 | — | $0 | 267,594 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2012-02-15 | 2012-02-17 | 22,396 | — | $0 | 22,396 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-02-14 | 2012-02-16 | 1,470 | $88.11 | $129.5K | 22,480 | SEC↗ |